Method for regulating and controlling mechanical properties of microcapsules

The mechanical properties of microcapsules are regulated by the 'post-filling' and 'pre-filling' methods, and the problem of regulating the mechanical properties of microcapsules is solved, and flexible regulation within the physiological range and wide application in the field of biomedical use is achieved.

CN118924702APending Publication Date: 2024-11-12SHANGHAI JIAOTONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410993361.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

There is a lack of a method for regulating the mechanical properties of microcapsules within a physiological range to explore the transduction mechanism of mechanical signals between cells and cells and further regulate cellular behavior.

Method used

Two methods are used: the mechanical properties of the microcapsule are regulated by reversibly changing the permeability of the microcapsule membrane or cross-linking support molecules. The 'post-filling' method uses support molecules to enter the microcapsules and the 'pre-filling' method to build a macromolecular network to regulate the mechanical properties of the microcapsules by embedding the supporting molecules and cross-linking them.

Benefits of technology

It has achieved flexible regulation of the mechanical properties of microcapsules within a physiological range, simulated cell matrix, used to explore mechanical signal transduction pathways, and applied in the biomedical field for drug screening, delivery, tissue engineering and disease treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924702A_ABST
    Figure CN118924702A_ABST
Patent Text Reader

Abstract

The invention discloses a method for regulating and controlling mechanical properties of microcapsules, and relates to the technical field of microcapsules. The method is selected from one or two of the following methods: (1) a post-filling method: reversibly changing the permeability of a micro-capsule membrane, and enabling supporting molecules to enter and remain in the micro-capsule in a post-filling manner so as to change the mechanical property of the micro-capsule; and (2) a'pre-filling 'method: embedding supporting molecules in the microcapsules in a'pre-filling' manner, and regulating and controlling the mechanical properties of the microcapsules by crosslinking the supporting molecules. According to the invention, the mechanical properties of the microcapsule can be regulated and controlled in a physiological range, other physical and biochemical properties of the microcapsule are not influenced, and the microcapsule can be applied to the fields of natural cell behavior regulation and control, in-vitro activation of natural cells, disease diagnosis and treatment, specific molecule delivery, local slow release and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of microcapsules, and in particular to a method for regulating the mechanical properties of microcapsules. Background Art

[0002] Microencapsulation technology has a wide range of applications in the biomedical field, including therapies for various diseases, such as controlled drug release, tumor treatment, vaccine delivery, and gene therapy. The mechanical properties in the microenvironment have a multi-faceted regulatory effect on cells, affecting the physiological or pathological behavior of cells, involving regulatory mechanisms at the cell morphology, biological behavior, and molecular levels. First, the mechanical environment around cells can affect the morphology and structure of cells. For example, when cells are subjected to external forces, they may change their shape or rearrange their cytoskeleton to adapt to such mechanical changes. Second, mechanical properties can also affect cell growth, migration, and differentiation. Cells may exhibit different biological behaviors in different mechanical environments. For example, on a harder matrix, cells may be more inclined to expand and migrate, while on a softer matrix, cells may be more inclined to proliferate and differentiate. In addition, mechanical properties can also affect the activity of intracellular signal transduction pathways, thereby regulating biological processes such as cell metabolism, protein expression, and cell fate determination.

[0003] However, there is currently a lack of a method to regulate the mechanical properties of microcapsules within the physiological range in order to explore the transduction mechanism of mechanical signals between cells and further regulate cell behavior. Therefore, there is an urgent need to solve related technical problems in order to better serve the biomedical field. Summary of the invention

[0004] In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to provide a microcapsule that can regulate the mechanical properties within a physiological range to explore the transduction mechanism of mechanical signals between cells.

[0005] To achieve the above object, the present invention provides a method for regulating the mechanical properties of microcapsules, which is selected from one or two of the following methods:

[0006] (1) “Post-filling” method: by reversibly changing the permeability of the microcapsule membrane, the supporting molecules are introduced into and retained inside the microcapsule through “post-filling” to change the mechanical properties of the microcapsule;

[0007] (2) “Pre-filling” method: The supporting molecules are embedded in the microcapsule by “pre-filling”, and the mechanical properties of the microcapsule are regulated by cross-linking the supporting molecules.

[0008] In a preferred embodiment of the present invention, in the "post-filling" method, the microcapsule is selected from polysaccharide-based microcapsules, and the organic molecules can reversibly change the intermolecular forces of the microcapsule membrane, further changing the permeability of the microcapsule membrane, so that the supporting molecules can diffuse and be retained inside the microcapsule by "post-filling"; in the "pre-filling" method, the microcapsule is selected from polysaccharide-based microcapsules; the supporting molecules are selected from natural or modified polypeptides, proteins, polysaccharides, nucleic acids and lipids with a molecular weight greater than or equal to 40 kDa, and one or more of polyethylene glycol and polyacrylamide synthetic macromolecules, preferably one or more of natural macromolecules such as bovine serum albumin, ovalbumin, gelatin, sodium alginate, hyaluronic acid, dextran, chitosan, chitosan oligosaccharides and their modified molecules after carboxylation, amination, and methacrylic acid acylation.

[0009] The present invention also discloses a method for regulating the mechanical properties of microcapsules by a "post-filling" method, comprising the following steps:

[0010] Step 1: preparing a calcium carbonate template: mixing (NH4)2CO3 solution, CaCl2 solution, carboxymethyl dextran solution and tannic acid solution by mechanical stirring, uniformly mixing and standing until the mixed solution is completely phase-separated, removing the supernatant, and washing the calcium carbonate template with deionized water to obtain a calcium carbonate template;

[0011] Step 2: preparing polysaccharide-based microcapsules: dispersing the calcium carbonate template in a HEPES buffer solution containing polysaccharides, vortexing the assembly, collecting the self-assembled template by centrifugation, and washing the template once with a HEPES solution. Subsequently, dispersing the template in a HEPES buffer solution containing polyethylene glycol modified with double-end NHS active esters, vortexing the cross-linking, collecting the cross-linked template by centrifugation, dispersing the template in an EDTA solution, standing the solution, collecting the microcapsules by centrifugation after the CaCO3 template is completely removed, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution to obtain polysaccharide-based microcapsules.

[0012] Step 3: regulating the mechanical properties of the microcapsules by "post-filling": dispersing the polysaccharide-based microcapsules in aqueous solutions of dissolving supporting molecules and organic solvents, respectively, mixing at room temperature, collecting the microcapsules by centrifugation, washing the microcapsules by centrifugation with deionized water, and then redispersing the microcapsules in pure water.

[0013] In a preferred embodiment of the present invention, in step 1, the concentration of the (NH4)2CO3 solution is 0.5 mol / L, the concentration of the CaCl2 solution is 2 mol / L, the concentration of the carboxymethyl dextran solution is 20 mg / mL, the molecular weight is 1.5 kDa, the concentration of the tannic acid solution is 1 mg / mL, and the volume ratio of the (NH4)2CO3 solution, the CaCl2 solution, the carboxymethyl dextran solution, and the tannic acid solution is 4:4:1:1;

[0014] In step 2, in the HEPES buffer solution in which polysaccharides are dissolved, the HEPES buffer solution concentration is 0.2 mM, pH 6.5, the polysaccharide concentration is 2 mg / mL, the polyethylene glycol concentration modified with double-ended NHS active ester is 2 mg / mL, and the polyethylene glycol molecular weight is 1 kDa, the EDTA solution concentration is 0.2 mol / L, pH 8.5, and the volume ratio of the HEPES buffer solution in which polysaccharides are dissolved, the HEPES buffer solution in which polyethylene glycol modified with double-ended NHS active ester is dissolved, and the EDTA solution is 3:5:10; the polysaccharide is selected from one or more natural polysaccharides such as dextran, hyaluronic acid, chitosan, alginate, xanthan gum, cellulose, starch, and their derivatives;

[0015] In step 3, in the aqueous solution of the supporting molecules and the organic solvent, the supporting macromolecules are selected from one or more of natural or modified polypeptides, proteins, polysaccharides, nucleic acids and lipids with a molecular weight greater than or equal to 40 kDa, and polyethylene glycol, polyacrylamide synthetic macromolecules, preferably one or more of natural macromolecules such as bovine serum albumin, ovalbumin, gelatin, sodium alginate, hyaluronic acid, dextran, chitosan, chitosan oligosaccharides and their modified molecules after carboxylation, amination, and methacrylic acid acylation; the organic molecules are selected from one or more of urea, ethanol, propanol, acetone, and dimethyl sulfoxide, and the concentration of the organic molecules in water is 5wt% to 60wt%.

[0016] The present invention also discloses a method for regulating the mechanical properties of microcapsules by a "pre-filling" method, comprising the following steps:

[0017] Step 1: preparing a calcium carbonate template for embedding supporting molecules: mixing Na2CO3 solution, CaCl2 solution, carboxymethyl dextran solution, tannic acid solution and supporting molecule solution uniformly by vortexing, standing until the mixed solution is completely phase-separated, removing the supernatant, and washing the calcium carbonate template for embedding supporting molecules with deionized water to obtain a calcium carbonate template for embedding supporting molecules;

[0018] Step 2: preparing microcapsules embedding supporting molecules: dispersing the prepared calcium carbonate template embedding supporting molecules in a HEPES buffer solution dissolved with polysaccharides, vortexing for assembly, centrifuging to collect the self-assembled template, and washing the template once with a HEPES solution, then dispersing the template in a HEPES buffer solution dissolved with carboxymethyl-modified dextran, NHS and EDC, vortexing for cross-linking, centrifuging to collect the cross-linked template, dispersing the template in an EDTA solution, standing, and after the CaCO3 template is completely removed, collecting the microcapsules embedding supporting molecules by centrifugation, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution;

[0019] Step 3: Regulate the mechanical properties of the "pre-filled" supporting molecules by cross-linking.

[0020] In a preferred embodiment of the present invention, in step 1, the concentration of the Na2CO3 solution is 1 mol / L, the concentration of the CaCl2 solution is 1 mol / L, the concentration of the supporting molecule solution is 0.5-30 mg / mL, the concentration of the tannic acid solution is 0.5 mg / mL, and the volume ratio of the Na2CO3 solution, the CaCl2 solution, the supporting molecule solution, and the tannic acid solution is 2:4:1:2;

[0021] In step 2, in the HEPES buffer solution of polysaccharide, the HEPES buffer solution concentration is 0.2mM, pH 6.5, the polysaccharide concentration is 2mg / mL, the carboxymethyl-modified dextran concentration is 2mg / mL, the molecular weight is 1.5kDa, the NHS concentration is 4mg / mL, the EDC concentration is 4mg / mL, and the volume ratio of the HEPES buffer solution of polysaccharide to the HEPES buffer solution in which the carboxymethyl-modified dextran, NHS and EDC are dissolved is 3:5; the polysaccharide is selected from one or more natural polysaccharides such as dextran, hyaluronic acid, chitosan, alginate, xanthan gum, cellulose, starch and their derivatives;

[0022] In step 3, the method of cross-linking the supporting molecules is selected from any one of the following two:

[0023] a. Covalently cross-linking the supporting molecules by adding a cross-linking agent, wherein the cross-linking agent molecule is a molecule carrying two or more amino groups, carboxyl groups, active esters or hydroxyl groups, preferably one or more selected from the group consisting of 500Da to 3kDa double-terminal amino-modified polyethylene glycol PEG, double-terminal active ester-modified PEG, double-terminal carboxyl-modified PEG, carboxymethyl dextran, hyaluronic acid, amino hyaluronic acid, and tannic acid; the concentration of the cross-linking agent molecule is 0.25mg / mL to 10mg / mL, and the cross-linking time is 30min to 24h;

[0024] b. Photo-crosslinking the supporting molecules containing photo-responsive groups by external illumination, wherein the photo-responsive groups are selected from methacrylate.

[0025] The present invention also discloses a method for regulating the mechanical properties of microcapsules by a "pre-filling" method, comprising the following steps:

[0026] Step 1: preparing microcapsules embedding supporting molecules: mixing a solution containing supporting molecules and polysaccharides with isooctyl alcohol under ultrasound, then dispersing the emulsion in a HEPES buffer containing double-end carboxyl-modified polyethylene glycol, EDC, and NHS, vortexing for cross-linking, centrifuging to collect the cross-linked microcapsules, dialyzing the microcapsules in an aqueous solution, and then centrifuging to collect the microcapsules embedding supporting molecules, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution;

[0027] Step 2: regulating the mechanical properties of the "pre-filled" supporting molecular microcapsules by cross-linking;

[0028] In a preferred embodiment of the present invention, in step 1, the concentration of the polysaccharide is 2 mg / mL, the concentration of the supporting molecule is 0.1-30 mg / mL, the concentration of the double-end carboxyl-modified polyethylene glycol is 2 mg / mL, the molecular weight of the polyethylene glycol is 3 kDa, the concentration of NHS is 4 mg / mL, and the concentration of EDC is 4 mg / mL;

[0029] In step 2, the method of cross-linking the supporting molecules is selected from any one of the following two:

[0030] a. The method comprises covalently cross-linking the supporting molecules by adding a cross-linking agent, wherein the cross-linking agent molecule is a molecule carrying two or more amino groups, carboxyl groups, active ester groups or hydroxyl groups, preferably one or more selected from the group consisting of polyethylene glycol PEG with a molecular weight of 500Da to 3kDa with double-end amino groups modified, PEG with double-end active esters modified, PEG with double-end carboxyl groups modified, carboxymethyl dextran, hyaluronic acid, aminohyaluronic acid and tannic acid; the concentration of the cross-linking agent molecule is 0.25mg / mL to 10mg / mL, and the cross-linking time is 30min to 24h;

[0031] b. Photo-crosslinking the supporting molecules containing photo-responsive groups by external illumination, wherein the photo-responsive groups are selected from methacrylate.

[0032] The present invention also discloses a method for regulating the mechanical properties of microcapsules by "pre-filling" and "post-filling" methods, comprising the following steps:

[0033] Step 1: preparing polysaccharide-based microcapsules embedding supporting molecules: mixing a solution containing supporting molecules A and polysaccharides with isooctyl alcohol under ultrasound, then dispersing the emulsion in a HEPES buffer containing double-end carboxyl-modified polyethylene glycol, EDC, and NHS, vortexing for cross-linking, centrifuging to collect the cross-linked microcapsules, dialyzing the microcapsules in an aqueous solution, and then centrifuging to collect the polysaccharide-based microcapsules embedding supporting molecules A, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution;

[0034] Step 2: The mechanical properties of the microcapsules are regulated by combining "pre-filling" and "post-filling": the prepared polysaccharide-based microcapsules with internally embedded supporting molecules A are dispersed in an aqueous solution containing supporting molecules B and an organic solvent, and mixed on a shaker at room temperature. After the mixing treatment, the microcapsules are collected by centrifugation, and the microcapsules are washed by centrifugation with deionized water, and then the microcapsules are redispersed in pure water.

[0035] In a preferred embodiment of the present invention, in step 1, the concentration of the polysaccharide is 0.1 mg / mL, the concentration of the supporting molecule A is 0.1-30 mg / mL, the concentration of the double-end carboxyl-modified polyethylene glycol is 2 mg / mL, the molecular weight of polyethylene glycol is 3 kDa, the concentration of NHS is 4 mg / mL, and the concentration of EDC is 4 mg / mL;

[0036] In step 2, the supporting molecule A or supporting molecule B is selected from natural or modified polypeptides, proteins, polysaccharides, nucleic acids and lipids with a molecular weight greater than or equal to 40 kDa, and one or more synthetic macromolecules including polyethylene glycol and polyacrylamide, preferably one or more natural macromolecules such as bovine serum albumin, ovalbumin, gelatin, sodium alginate, hyaluronic acid, dextran, chitosan, chitosan oligosaccharides and their modified molecules after carboxylation, amination, and methacrylic acid acylation; the organic molecule is selected from one or more of urea, ethanol, propanol, acetone, and dimethyl sulfoxide, and the concentration of the organic molecule in water is 5wt% to 60wt%.

[0037] Compared with the prior art, the present invention has the following beneficial effects:

[0038] The present invention is based on the self-assembly of macromolecules driven by supramolecular forces, and further constructs microcapsules through cross-linking of macromolecules. In this process, a macromolecular network that mimics a "cell matrix" is formed inside the microcapsule by "pre-filling" with specific macromolecules embedded inside the microcapsule, or by "post-filling" the macromolecules inside the microcapsule by increasing membrane permeability after the microcapsule is formed, thereby achieving regulation of the mechanical properties of the microcapsule. The regulation of the mechanical properties is mainly achieved through the chemical structure, molecular weight, concentration, and degree of cross-linking of the internal macromolecular network structure.

[0039] The present invention can achieve regulation of the mechanical properties of microcapsules within the physiological range, that is, the deformation, stress distribution and response ability of the microcapsules to the external physical and mechanical environment under the action of external forces can be flexibly regulated and characterized in a variety of ways, including stiffness, elastic modulus, viscoelasticity, etc., without affecting other physical and biochemical properties of the microcapsules.

[0040] The microcapsules constructed by the present invention can not only simulate the mechanical properties of natural cells and tissues, but also be used to explore the mechanical signal transduction pathways in the body, and further applied to the biomedical field, suitable for drug screening and delivery, tissue engineering, disease treatment, biosensors and other biomedical fields. Preferably, the microcapsules can be used in the fields of regulating natural cell behavior, activating natural cells in vitro, disease diagnosis and treatment, specific molecule delivery, local sustained release, etc.

[0041] The concept, specific structure and technical effects of the present invention will be further described below in conjunction with the accompanying drawings to fully understand the purpose, characteristics and effects of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 Schematic diagram of regulating the mechanical properties of microcapsules through "pre-filling" and "post-filling" methods in an embodiment of the present invention;

[0043] Figure 2 This is a morphological diagram of the mechanical properties of microcapsules regulated by the "post-filling" method in an embodiment of the present invention;

[0044] Figure 3 This is a morphological diagram of the mechanical properties of microcapsules regulated by the "pre-filling" method in an embodiment of the present invention;

[0045] Figure 4 Atomic force microscope morphology images of microcapsules with different mechanical properties constructed according to the embodiments of the present invention. DETAILED DESCRIPTION

[0046] The following describes several preferred embodiments of the present invention with reference to the drawings in the specification, so that the technical content is clearer and easier to understand. The present invention can be embodied in many different forms of embodiments, and the protection scope of the present invention is not limited to the embodiments mentioned in the text.

[0047] In the drawings, components with the same structure are indicated by the same numerical reference numerals, and components with similar structures or functions are indicated by similar numerical reference numerals. The size and thickness of each component shown in the drawings are arbitrarily shown, and the present invention does not limit the size and thickness of each component. In order to make the illustration clearer, the thickness of the components is appropriately exaggerated in some places in the drawings.

[0048] Example 1 Method for regulating the mechanical properties of microcapsules by "post-filling" method

[0049] 1. Preparation of calcium carbonate template

[0050] (1) 2 mL of 0.5 mol / L (NH4)2CO3 solution, 2 mL of 2 mol / L CaCl2, 0.5 mL of 20 mg / mL carboxymethyl dextran (molecular weight = 1.5 kDa) solution, and 0.5 mL of 1 mg / mL tannic acid solution were mixed by mechanical stirring at 600 rpm for 40 seconds.

[0051] (2) After mixing, the mixture was allowed to stand for 1-2 hours until the mixture was completely separated into different phases.

[0052] (3) After removing the supernatant, the calcium carbonate template is washed with deionized water. The diameter of the prepared template is 25-30 μm.

[0053] 2. Preparation of Hyaluronic Acid-Based Microcapsules

[0054] (1) The calcium carbonate template prepared in Example 1 was dispersed in 3 mL of HEPES buffer solution (0.2 mM, pH = 6.5) containing 2 mg / mL dextran, and vortexed at 1000 rpm for 1 h.

[0055] (2) Collect the self-assembled template by centrifugation and wash the template once with HEPES solution.

[0056] (3) Subsequently, the template was dispersed in 5 mL of HEPES buffer containing 2 mg / mL double-terminal NHS active ester-modified polyethylene glycol (PEG, molecular weight = 1 kDa) and vortexed at 1000 rpm for 3 h for cross-linking.

[0057] (4) The cross-linked template was collected by centrifugation, dispersed in 10 mL of 0.2 mol / L EDTA solution (pH = 8.5), and allowed to stand for 10 minutes.

[0058] (5) After the CaCO3 template is completely removed, the microcapsules are collected by centrifugation, washed with PBS solution, and redispersed in the PBS solution.

[0059] 3. Regulating the mechanical properties of microcapsules by “post-filling”

[0060] (1) The prepared hyaluronic acid-based microcapsules were dispersed in urea solutions containing 5 mg / mL and 15 mg / mL sodium alginate (urea concentration was 30 wt%), respectively, and mixed on a shaker at room temperature for 6 h. After the mixing treatment, the microcapsules were collected by centrifugation, washed twice by centrifugation with deionized water, and redispersed in pure water.

[0061] After testing, the Young's modulus of the microcapsule before urea treatment was 1000Pa, the Young's modulus of the microcapsule after 5mg / mL sodium alginate treatment was 3.5kPa, and the Young's modulus of the microcapsule after 15mg / mL sodium alginate treatment was 6.5kPa.

[0062] Example 2 Method for regulating the mechanical properties of microcapsules by "pre-filling" method

[0063] 1. Preparation of calcium carbonate template for embedding methacrylated gelatin (GelMA)

[0064] (1) 1 mL of 1 mol / L Na2CO3 solution, 2 mL of 1 mol / L CaCl2, 0.5 mL of 15 mg / mL carboxymethyl dextran (molecular weight = 1.5 kDa) solution, 0.5 mL of 0.5 mg / mL tannic acid solution, and 1 mL of 15 mg / mL methacrylated gelatin (molecular weight = 150 kDa) solution were mixed by vortexing at 800 rpm for 30 seconds.

[0065] (2) After mixing, the mixture was allowed to stand for 1 hour until the mixture was completely separated into different phases.

[0066] (3) After removing the supernatant, the calcium carbonate template embedded with GelMA was washed with deionized water. The diameter of the prepared template was 15-20 μm.

[0067] 2. Preparation of GelMA-encapsulated dextran-based microcapsules

[0068] (1) The prepared GelMA-embedded calcium carbonate template was dispersed in 3 mL of HEPES buffer solution (0.2 mM, pH = 6.5) dissolved with 2 mg / mL amino-modified hyaluronic acid, and vortexed at 1000 rpm for 1 h.

[0069] (2) Collect the self-assembled template by centrifugation and wash the template once with HEPES solution.

[0070] (3) Subsequently, the template was dispersed in 5 mL of HEPES buffer containing 2 mg / mL carboxymethyl-modified dextran (molecular weight = 1.5 kDa), 4 mg / mL NHS, and 4 mg / mL EDC, and vortexed at 1000 rpm for 4 h for cross-linking.

[0071] (4) The cross-linked template was collected by centrifugation, dispersed in 10 mL of 0.05 mol / L EDTA solution (pH = 7.5), and allowed to stand for 10 minutes.

[0072] (5) After the CaCO3 template is completely removed, the microcapsules embedded with GelMA are collected by centrifugation, the microcapsules are washed with PBS solution, and the microcapsules are redispersed in PBS solution.

[0073] 3. Regulating the mechanical properties of “pre-filled” GelMA microcapsules by photocrosslinking

[0074] (1) The prepared microcapsules filled with GelMA were dispersed in a solution of lithium phenyl-2.4.6-trimethylbenzoyl phosphite (LAP, concentration = 0.25% w / v).

[0075] (2) Irradiate the mixed solution with UV light for 10 s, 30 s and 1 min respectively.

[0076] After testing, the Young's modulus of the microcapsule before UV irradiation treatment was 800 Pa, the Young's modulus of the microcapsule after 10s UV irradiation was 3.5kPa, the Young's modulus of the microcapsule after 30s UV irradiation was 50kPa, and the Young's modulus of the microcapsule after 1min UV irradiation was 200kPa.

[0077] Example 3 Method for regulating the mechanical properties of microcapsules by "pre-filling" method

[0078] 1. Preparation of chitosan oligosaccharide microcapsules encapsulating HA-NH2

[0079] (1) A solution containing 0.1 mg / mL HA-NH2 and 3 mg / mL HA-NH2 chitosan oligosaccharide was mixed with isooctyl alcohol under ultrasound for 30 seconds.

[0080] (2) Subsequently, the emulsion was dispersed in 5 mL of HEPES buffer containing 2 mg / mL double-end carboxyl-modified polyethylene glycol (PEG, molecular weight = 3 kDa), 4 mg / mL EDC, and 4 mg / mL NHS, and vortexed at 1000 rpm for 12 h for cross-linking.

[0081] (3) The cross-linked microcapsules were collected by centrifugation and dialyzed in an aqueous solution for 3 days.

[0082] (4) Collect the microcapsules encapsulating HA-NH2 by centrifugation, wash the microcapsules with PBS solution, and redisperse the microcapsules in PBS solution.

[0083] 2. Modulating the mechanical properties of “pre-filled” HA-NH2 microcapsules by covalent cross-linking

[0084] (1) The prepared microcapsules filled with HA-NH2 were dispersed in solutions containing PEG molecules with double-end NHS modification (molecular weight of 1 kDa, concentrations of 1 mg / mL, 5 mg / mL and 10 mg / mL, respectively).

[0085] (2) Cross-linking treatment at room temperature for 4 h.

[0086] After testing, the Young's modulus of the microcapsule before covalent crosslinking treatment was 5 kPa, the Young's modulus of the microcapsule after crosslinking with 1 mg / mL crosslinking agent was 7.5 kPa, the Young's modulus of the microcapsule after crosslinking with 5 mg / mL crosslinking agent was 50 kPa, and the Young's modulus of the microcapsule after crosslinking with 10 mg / mL crosslinking agent was 1 MPa.

[0087] Example 4: Controlling the mechanical properties of microcapsules by combining "pre-filling" and "post-filling" 1. Preparation of chitosan oligosaccharide-based microcapsules encapsulating HA-NH2

[0088] (1) A solution containing 0.1 mg / mL HA-NH2 and 3 mg / mL HA-NH2 chitosan oligosaccharide was mixed with isooctyl alcohol under ultrasound for 30 seconds.

[0089] (2) Subsequently, the emulsion was dispersed in 5 mL of HEPES buffer containing 2 mg / mL double-end carboxyl-modified polyethylene glycol (PEG, molecular weight = 3 kDa), 4 mg / mL EDC, and 4 mg / mL NHS, and vortexed at 1000 rpm for 12 h for cross-linking.

[0090] (3) The cross-linked microcapsules were collected by centrifugation and dialyzed in an aqueous solution for 3 days.

[0091] (4) Collect the microcapsules encapsulating HA-NH2 by centrifugation, wash the microcapsules with PBS solution, and redisperse the microcapsules in PBS solution.

[0092] 2. Regulating the mechanical properties of microcapsules by combining “pre-filling” and “post-filling”

[0093] (1) The prepared microcapsules filled with HA-NH2 were dispersed in urea solutions containing 5 mg / mL and 15 mg / mL sodium alginate (urea concentration was 30 wt%), respectively, and mixed on a shaker at room temperature for 6 h. After the mixing treatment, the microcapsules were collected by centrifugation, washed twice by centrifugation with deionized water, and redispersed in pure water.

[0094] After testing, the Young's modulus of the microcapsule before urea treatment was 2kPa, the Young's modulus of the microcapsule after 5mg / mL sodium alginate treatment was 35kPa, and the Young's modulus of the microcapsule after 15mg / mL sodium alginate treatment was 100kPa.

[0095] The preferred specific embodiments of the present invention are described in detail above. It should be understood that ordinary technicians in the field can make many modifications and changes based on the concept of the present invention without creative work. Therefore, all technical solutions that can be obtained by technicians in the technical field based on the concept of the present invention through logical analysis, reasoning or limited experiments on the basis of the prior art should be within the scope of protection determined by the claims.

Claims

1. A method for regulating the mechanical properties of microcapsules, characterized in that: Choose one or both of the following methods: (1) "Post-filling" method: by reversibly changing the permeability of the microcapsule membrane, the supporting molecules are introduced into and retained inside the microcapsule through "post-filling" to change the mechanical properties of the microcapsule; (2) "Pre-filling" method: The supporting molecules are embedded in the microcapsule by "pre-filling" and the mechanical properties of the microcapsule are regulated by cross-linking the supporting molecules.

2. The method for regulating the mechanical properties of microcapsules according to claim 1, characterized in that: In the "post-filling" method, the microcapsule is selected from polysaccharide-based microcapsules, and the organic molecules can reversibly change the intermolecular forces of the microcapsule membrane, further changing the permeability of the microcapsule membrane, so that the supporting molecules can diffuse and be retained inside the microcapsule through the "post-filling" method; in the "pre-filling" method, the microcapsule is selected from polysaccharide-based microcapsules; the supporting molecules are selected from one or more of natural or modified polypeptides, proteins, polysaccharides, nucleic acids and lipids with a molecular weight greater than or equal to 40kDa, and polyethylene glycol, polyacrylamide synthetic macromolecules.

3. A method for regulating the mechanical properties of microcapsules by a "post-filling" method, characterized in that: The steps include: Step 1: preparing a calcium carbonate template: mixing (NH4)2CO3 solution, CaCl2 solution, carboxymethyl dextran solution and tannic acid solution by mechanical stirring, uniformly mixing and standing until the mixed solution is completely phase-separated, removing the supernatant, and washing the calcium carbonate template with deionized water to obtain a calcium carbonate template; Step 2: preparing polysaccharide-based microcapsules: dispersing the calcium carbonate template in a HEPES buffer solution containing polysaccharides, vortexing the assembly, collecting the self-assembled template by centrifugation, and washing the template once with a HEPES solution. Subsequently, dispersing the template in a HEPES buffer solution containing polyethylene glycol modified with double-end NHS active esters, vortexing the cross-linking, collecting the cross-linked template by centrifugation, dispersing the template in an EDTA solution, standing the solution, collecting the microcapsules by centrifugation after the CaCO3 template is completely removed, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution to obtain polysaccharide-based microcapsules. Step 3: The mechanical properties of the microcapsules are regulated by "post-filling": the polysaccharide-based microcapsules are dispersed in aqueous solutions of dissolving supporting molecules and organic solvents, respectively, mixed at room temperature, collected by centrifugation, and washed by centrifugation with deionized water, and then redispersed in pure water.

4. The method for regulating the mechanical properties of microcapsules by the "post-filling" method according to claim 3, characterized in that: In step 1, the concentration of the (NH4)2CO3 solution is 0.5 mol / L, the concentration of the CaCl2 solution is 2 mol / L, the concentration of the carboxymethyl dextran solution is 20 mg / mL, the molecular weight is 1.5 kDa, the concentration of the tannic acid solution is 1 mg / mL, and the volume ratio of the (NH4)2CO3 solution, the CaCl2 solution, the carboxymethyl dextran solution, and the tannic acid solution is 4:4:1:1; In step 2, in the HEPES buffer solution in which polysaccharides are dissolved, the HEPES buffer solution concentration is 0.2 mM, pH 6.5, the polysaccharide concentration is 2 mg / mL, the polyethylene glycol concentration modified with double-ended NHS active ester is 2 mg / mL, and the polyethylene glycol molecular weight is 1 kDa, the EDTA solution concentration is 0.2 mol / L, pH 8.5, and the volume ratio of the HEPES buffer solution in which polysaccharides are dissolved, the HEPES buffer solution in which polyethylene glycol modified with double-ended NHS active ester is dissolved, and the EDTA solution is 3:5:10; the polysaccharide is selected from one or more natural polysaccharides such as dextran, hyaluronic acid, chitosan, alginate, xanthan gum, cellulose, starch, and their derivatives; In step 3, in the aqueous solution of the supporting molecule and the organic solvent, the supporting molecule is selected from one or more of natural or modified polypeptides, proteins, polysaccharides, nucleic acids and lipids with a molecular weight greater than or equal to 40 kDa, and polyethylene glycol, polyacrylamide synthetic macromolecules; the organic molecule is selected from one or more of urea, ethanol, propanol, acetone, dimethyl sulfoxide, and the concentration of the organic molecule in water is 5wt% to 60wt%.

5. A method for regulating the mechanical properties of microcapsules by a "pre-filling" method, characterized in that: The steps include: Step 1: preparing a calcium carbonate template for embedding supporting molecules: mixing Na2CO3 solution, CaCl2 solution, carboxymethyl dextran solution, tannic acid solution and supporting molecule solution uniformly by vortexing, standing until the mixed solution is completely phase-separated, removing the supernatant, and washing the calcium carbonate template for embedding supporting molecules with deionized water to obtain a calcium carbonate template for embedding supporting molecules; Step 2: preparing microcapsules embedding supporting molecules: dispersing the prepared calcium carbonate template embedding supporting molecules in a HEPES buffer solution dissolved with polysaccharides, vortexing for assembly, centrifuging to collect the self-assembled template, and washing the template once with a HEPES solution, then dispersing the template in a HEPES buffer solution dissolved with carboxymethyl-modified dextran, NHS and EDC, vortexing for cross-linking, centrifuging to collect the cross-linked template, dispersing the template in an EDTA solution, standing, and after the CaCO3 template is completely removed, collecting the microcapsules embedding supporting molecules by centrifugation, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution; Step 3: Regulate the mechanical properties of the "pre-filled" supporting molecules by cross-linking.

6. The method for regulating the mechanical properties of microcapsules by the "pre-filling" method according to claim 5, characterized in that: In step 1, the concentration of the Na2CO3 solution is 1 mol / L, the concentration of the CaCl2 solution is 1 mol / L, the concentration of the supporting molecule solution is 0.5-30 mg / mL, the concentration of the tannic acid solution is 0.5 mg / mL, and the volume ratio of the Na2CO3 solution, the CaCl2 solution, the supporting molecule solution, and the tannic acid solution is 2:4:1:2; In step 2, in the HEPES buffer solution of polysaccharide, the HEPES buffer solution concentration is 0.2mM, pH 6.5, the polysaccharide concentration is 2mg / mL, the carboxymethyl-modified dextran concentration is 2mg / mL, the molecular weight is 1.5kDa, the NHS concentration is 4mg / mL, the EDC concentration is 4mg / mL, and the volume ratio of the HEPES buffer solution of polysaccharide to the HEPES buffer solution in which the carboxymethyl-modified dextran, NHS and EDC are dissolved is 3:5; the polysaccharide is selected from one or more natural polysaccharides such as dextran, hyaluronic acid, chitosan, alginate, xanthan gum, cellulose, starch and their derivatives; In step 3, the method of cross-linking the supporting molecules is selected from any one of the following two: a. Covalently cross-linking the supporting molecules by adding a cross-linking agent, wherein the cross-linking agent molecule is a molecule carrying two or more amino groups, carboxyl groups, active ester groups or hydroxyl groups; the concentration of the cross-linking agent molecule is 0.25 mg / mL to 10 mg / mL, and the cross-linking time is 30 min to 24 h; b. Photo-crosslinking the supporting molecules containing photo-responsive groups by external illumination, wherein the photo-responsive groups are selected from methacrylate.

7. A method for regulating the mechanical properties of microcapsules by a "pre-filling" method, characterized in that: The steps include: Step 1: preparing microcapsules embedding supporting molecules: mixing a solution containing supporting molecules and polysaccharides with isooctyl alcohol under ultrasound, then dispersing the emulsion in a HEPES buffer containing double-end carboxyl-modified polyethylene glycol, EDC, and NHS, vortexing for cross-linking, centrifuging to collect the cross-linked microcapsules, dialyzing the microcapsules in an aqueous solution, and then centrifuging to collect the microcapsules embedding supporting molecules, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution; Step 2: The mechanical properties of the "pre-filled" supporting molecular microcapsules are regulated by cross-linking.

8. The method for regulating the mechanical properties of microcapsules by the "pre-filling" method according to claim 7, characterized in that: In step 1, the concentration of the polysaccharide is 2 mg / mL, the concentration of the supporting molecule is 0.1-30 mg / mL, the concentration of the double-end carboxyl-modified polyethylene glycol is 2 mg / mL, the molecular weight of polyethylene glycol is 3 kDa, the concentration of NHS is 4 mg / mL, and the concentration of EDC is 4 mg / mL; In step 2, the method of cross-linking the supporting molecules is selected from any one of the following two: a. Covalent cross-linking of supporting molecules by adding a cross-linking agent, wherein the cross-linking agent molecule is a molecule carrying two or more amino groups, carboxyl groups, active esters or hydroxyl groups; the concentration of the cross-linking agent molecule is 0.25 mg / mL to 10 mg / mL, and the cross-linking time is 30 min to 24 h; b. Photo-crosslinking the supporting molecules containing photo-responsive groups by external illumination, wherein the photo-responsive groups are selected from methacrylate.

9. A method for regulating the mechanical properties of microcapsules by "pre-filling" and "post-filling" methods, characterized in that: The steps include: Step 1: preparing polysaccharide-based microcapsules embedding supporting molecules: mixing a solution containing supporting molecules A and polysaccharides with isooctyl alcohol under ultrasound, then dispersing the emulsion in a HEPES buffer containing double-end carboxyl-modified polyethylene glycol, EDC, and NHS, vortexing for cross-linking, centrifuging to collect the cross-linked microcapsules, dialyzing the microcapsules in an aqueous solution, and then centrifuging to collect the polysaccharide-based microcapsules embedding supporting molecules A, washing the microcapsules with a PBS solution, and redispersing the microcapsules in a PBS solution; Step 2: The mechanical properties of the microcapsules are regulated by combining "pre-filling" and "post-filling": the prepared polysaccharide-based microcapsules with internally embedded supporting molecules A are dispersed in an aqueous solution containing supporting molecules B and an organic solvent, and mixed on a shaker at room temperature. After the mixing treatment, the microcapsules are collected by centrifugation, and the microcapsules are washed by centrifugation with deionized water, and then the microcapsules are redispersed in pure water.

10. The method for regulating the mechanical properties of microcapsules by "pre-filling" and "post-filling" methods according to claim 9, characterized in that: In step 1, the concentration of the polysaccharide is 0.1 mg / mL, the concentration of the supporting molecule A is 0.1-30 mg / mL, the concentration of the double-end carboxyl-modified polyethylene glycol is 2 mg / mL, the molecular weight of polyethylene glycol is 3 kDa, the concentration of NHS is 4 mg / mL, and the concentration of EDC is 4 mg / mL; In step 2, the supporting molecule A or supporting molecule B is selected from one or more of natural or modified polypeptides, proteins, polysaccharides, nucleic acids and lipids with a molecular weight greater than or equal to 40 kDa, and polyethylene glycol, polyacrylamide synthetic macromolecules; the organic molecule is selected from one or more of urea, ethanol, propanol, acetone, and dimethyl sulfoxide, and the concentration of the organic molecule in water is 5wt% to 60wt%.